MS disease activity in RESTORE: A randomized 24-week natalizumab treatment interruption study
Simultaneous EEG-fMRI recordings were performed in 13 children with myoclonic astatic epilepsy. Individual generalized spike and wave discharges associated with blood oxygenation level-dependent signal changes were analyzed in every patient. The results demonstrated that somatosensory cortex, putamen, and cerebellum are involved in the generation of myoclonic seizures. This trial tested doses of the study drug, an inhibitor of the receptor for advanced glycation end products (RAGE), vs placebo in patients with Alzheimer disease over 18 months. The higher dose was stopped due to falls and confusion and the lower dose was discontinued later as a result of a futility analysis. Post-futility analyses were ambiguous; however, the lower dose had benefits on the Alzheimer's Disease Assessment Scale-cognitive. 
